文献库搜索 | GeneLibs

Arbouche(N),Traenklé(C),Raul(JS),Kintz(P) Clin Chim Acta 2026-04-01

...ALK) inhibitor used for the treatment of ALK-rearranged non-small-cell lung cancer (NSCLC). While its quantification in ...

Dileep(A),Cowper(SE),Panse(G) J Cutan Pathol 2026-06-00

...ALK immunoreactivity typical of EFH. All three cases occurred in adults and were present on the trunk or extremities. Th...

Ma(W),Zhou(S),Lu(J),Wei(H),Huang(Y) Front Oncol None

...ALK. Fluorescence in situ hybridization (FISH) demonstrated ALK gene rearrangements. The patient was disease-free after ...

Shumilov(E),Ngoya(M),Berning(P),Devillier(... J Hematol Oncol 2026-02-21

...ALK)-negative ALCL. We compared imaging by computed tomography (CT) or positron emission tomography (PET) for defining d...

Takayanagi(H),Masui(R),Mori(M),Oku(N),Yama... Org Lett 2026-03-06

...alk-1-enes is reported. 1,1-Di(boryl)alk-1-enes are deprotonated at the γ-position to generate α,α-di(boryl)allyl anions...

Kapoor(A),Singh(AK),Chaudhary(M),Gupta(A),... Case Rep Oncol Med None

...ALK tyrosine kinase inhibitors (TKIs) such as alectinib remains inevitable. We report a young, nonsmoker male with ALK-p...

El-Kersh(K),Zawadzki(N),Coyle(C),Zhang(S),... J Mark Access Health Policy 2026-03-00

...ALK+) non-small-cell lung cancer and renal cell carcinoma were most similar in therapeutic landscape. Although no single...

Acosta Suárez(S),Barón Méndez(LE),Romero L... Rare Tumors None

...ALK-1-positive, confirming IMT. Post-operative bronchoscopy on day seven showed a widely patent airway. Five years later...

Hernandez(DA),Petersen(G),Gonzalez-Salido(... J Chemother 2026-02-23

...ALK-positive disease accounts for roughly 5% of cases We conducted a systematic search of PubMed, Embase, Cochrane, Web ...

Delasos(L),Hassan(KA) JCO Oncol Pract 2026-07-00

...ALK, ROS1, and RET. Collectively, these advances herald a new era of precision oncology in NSCLC, where targeted therapi...